Aims & Scope

Dharmaputra Medical Law Journal (DMLJ)

Jurnal Dharmaputra Hukum Kesehatan

P-ISSN: 3124-1964 | E-ISSN: 3124-1840

Journal Aims

 
Academic Excellence

To advance high-quality, rigorous scholarship in the field of medical law through double-blind peer review and adherence to international publication standards, establishing DMLJ as the leading Indonesian journal in this discipline.

 
Interdisciplinary Bridge

To serve as a scholarly bridge between legal academia and medical practice, facilitating dialogue among lawyers, clinicians, ethicists, policymakers, and researchers on pressing medico-legal issues affecting Indonesian society.

 
Policy Contribution

To contribute evidence-based, scholarly analysis that informs health law reform, regulatory development, and the improvement of healthcare governance within Indonesia, drawing on comparative international experience.

 
International Visibility

To promote the visibility of Indonesian medical law scholarship on the global stage through Diamond Open Access, bilingual publication, and strategic indexing in international databases including DOAJ and Scopus.

Scope of the Journal

DMLJ welcomes original scholarly contributions that address the legal, regulatory, ethical, and governance dimensions of medicine, healthcare systems, and public health. Articles may be theoretical, doctrinal, empirical, or comparative in approach. The journal's scope encompasses but is not limited to the following thematic areas:

 
Medical Law & Litigation

Civil and criminal liability of healthcare providers, medical negligence, standards of care, and dispute resolution including mediation and health courts.

 
Health Regulations & Policy

Analysis of health legislation, regulatory reform, licensing regimes, national health insurance (JKN/BPJS Kesehatan), and comparative health law.

 
Bioethics & Research Ethics

Informed consent, end-of-life decisions, organ transplantation, reproductive technology, genetics, clinical trial ethics, and the governance of human subjects research.

 
Patient Rights & Protection

Right to access care, right to information, confidentiality, refusal of treatment, patient safety law, rights of vulnerable and marginalised patient groups.

 
Healthcare Professional Liability

Professional discipline, disciplinary tribunals (MKDKI/MKEK), licensing and registration, scope of practice, and employment law in healthcare settings.

 
Pharmaceutical & Drug Law

Regulation of pharmaceuticals, medical devices, BPOM oversight, drug pricing, access to essential medicines, and product liability in healthcare.

 
Health Insurance & Financing Law

Legal frameworks governing health financing, social health insurance, private insurance regulation, payment mechanisms, and equitable access to covered services.

 
Digital Health & Telemedicine Law

Legal frameworks for telemedicine, e-prescribing, electronic health records, health data privacy, AI in diagnostics, and cross-border digital health services.

Article Types Accepted

DMLJ accepts the following types of scholarly contributions:

Original Research Review Articles Case Studies Legal Analysis Policy Analysis Perspectives Letters to the Editor Book Reviews
Article Type Word Count (excl. references)
Original Research 4,000 – 8,000 words
Review Articles 5,000 – 10,000 words
Case Studies / Legal Analysis 3,000 – 7,000 words
Policy Analysis / Perspectives 2,000 – 5,000 words
Letters to the Editor Up to 800 words
Book Reviews 800 – 1,500 words

Language Policy

 
English

English is the preferred language of submission and is recommended for authors seeking maximum international reach and indexing visibility. All structural elements — title, abstract, keywords, and headings — must be provided in English.

 
Bahasa Indonesia

Bahasa Indonesia manuscripts are fully accepted. Authors submitting in Bahasa Indonesia must provide an English title, an English abstract (minimum 200 words), and English keywords. The full text may remain in Bahasa Indonesia.

Out of Scope

The following categories of submission fall outside DMLJ's scope and will not be considered for peer review:

Purely clinical articles without a legal angle. Manuscripts that are exclusively clinical in nature — reporting clinical findings, treatment outcomes, diagnostic accuracy studies, or pharmacological trials — without an identifiable legal, regulatory, or ethical dimension will not be considered.

General medical or biomedical research. Articles whose primary contribution is to biomedical science, epidemiology, or clinical medicine — without substantive legal, policy, or ethical analysis — are not within scope and should be directed to clinical or public health journals.

Policy advocacy without scholarly analysis. Opinion pieces, editorials, or advocacy documents that propose policy positions without grounding in legal analysis, empirical evidence, or engagement with the academic literature are not suitable for submission. All contributions must meet scholarly standards.

Principal Contact: Gede Krisna Udiana, S.K.M., M.H.Kes.  |  +62 812-3898-787  |  udiana.krisna@gmail.com

https://dmedlaw.org